Home twitter instagram

Biography Sharon BLINKOFF



Ms. Blinkoff represents manufacturers, marketers, and distributors of
cosmetics, dietary supplements, over the counter drugs, and medical
devices as well as beauty appliances and other consumer products and
luxury goods. Ms. Blinkoff regularly advises clients on compliance with
the laws enforced by the FDA, CPSC, and the FTC, and obtaining FDA
registrations and 510k premarket clearances.
For many years Ms. Blinkoff has played a leadership role in the Cosmetics
and Personal Care Industry serving on the Board of Directors and as
Corporate Secretary for the Independent Cosmetic Manufacturers and
Distributors (ICMAD) Trade Association. Ms. Blinkoff on behalf of
ICMAD has served as part of the industry negotiating team that met with
representatives of the US FDA to develop a framework for new Cosmetic
legislation. Ms Blinkoff has also been an active participant on behalf of
the industry, by submitting comments on FDA’s proposed changes to the
OTC Monograph proceedings and the proposal to require IND’s for
cosmetic testing, as well as other regulatory proceedings both state and
federal that impact on the Cosmetic and Personal Care industry.


Having served as Division and Regulatory Counsel for Bristol-Myers
Squibb/Fortis Clairol Division, as well as Senior Counsel for Revlon, Ms.
Blinkoff brings considerable experience in representing regulated
businesses on a broad range of regulatory and business matters. Ms.
Blinkoff also served as General Counsel to Ethan Allen Inc. and was part
of the management group that restructured the company and took it
public. With her broad regulatory experience and business background,
Ms. Blinkoff brings considerable knowledge and expertise to the
challenges faced by her clients. Having spent her early career as a patent
attorney for the National Institutes of Health, Ms. Blinkoff also brings a
keen understanding of the technical side of the regulatory process and the
interplay between regulatory issues and IP assets and how they relate to
the client’s business strategy.
Ms. Blinkoff has successfully defended clients in regulatory proceedings
before the FDA and the FTC, and has instituted and defended clients in
advertising challenges before the NAD, ERSP and the FTC as well as in Lanham Act

litigations. She has also assisted in the structuring business transactions involving

regulated products and industries, including corporate acquisitions and divestitures,

public offerings, joint venture and distribution agreements.